Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Is The In-Vitro Lung Model Market Expected To Grow In Terms Of Size?

The market size of the in-vitro lung model has increased at a rapid pace in the past few years. Its value is projected to expand from $0.44 billion in 2024 to $0.54 billion in 2025, with a compound annual growth rate (CAGR) of 21.0%. The impressive growth during the historic time frame can be traced back to a rise in the incidences of respiratory ailments, augmented emphasis on individualized treatment strategies, an increasing curiosity in repurposing drugs, focusing on precise medical approaches, and an escalating cognizance of environmental health hazards.

The market size for in-vitro lung models is projected to experience significant growth in the coming years, swelling to “$1.11 billion by 2029” with a compound annual growth rate (CAGR) of 19.8%. This expected surge in the future can be credited to several factors such as the necessity for drug development, the rise in preclinical trials, heightened awareness about respiratory toxicology, emphasis on regenerative medicine, escalating environmental concerns, and an upward trend in the geriatric population. The forecast period sees key trends like a growing demand for drug testing, improvements in 3D printing technology, progress in organ-on-chip technology, the application of AI and machine learning, incorporation of sensors and monitoring equipment, broadening of applications out of the pharmaceutical sphere, and the creation of disease-specific models.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15837&type=smp

What Core Drivers Are Expected To Influence The In-Vitro Lung Model Market?

The expansion of the in vitro lung model market is projected to be propelled by the rising number of clinical trials. The surge in clinical studies owes to the escalating demand for sophisticated medical interventions, increased healthcare requirements, and the search for innovative remedies to challenging health matters. Clinical studies are research endeavors that evaluate the efficacy of fresh medical methods in humans. In vitro lung models contribute to these trials by offering a regulated environment for studying the impacts of compounds on lung tissue, facilitating drug screening, toxicity evaluation, disease simulation and deciphering disease processes. For example, as of January 2024, data from ClinicalTrials.gov, a clinical trial registry based in the US, showed an uptick in registered clinical trials worldwide, rising to 477,230 by the end of 2023 from 437,508 in 2022. Consequently, the escalation in clinical trials spurs the growth of the in vitro lung model market.

Which Segments Define The Structure Of The In-Vitro Lung Model Market?

The in-vitro lung model market covered in this report is segmented –

1) By Type: Two-Dimensional (2D) Model, Three-Dimensional (3D) Model

2) By Application: Drug Discovery And Toxicology Studies, Physiological Research, Three-Dimensional (3D) Model Development, Other Applications

3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Two-Dimensional (2D) Model: Monolayer Cell Cultures, Co-cultures

2) By Three-Dimensional (3D) Model: Spheroids, Organoids, Lung-On-A-chip Models

What Strategic Shifts And Innovations Are Influencing The In-Vitro Lung Model Market?

Major firms in the invitro lung model market are innovating by creating three-dimensional (3D) respiratory tissue models to increase physiological relevance and intricacy within their models. These models are produced by cultivating specific respiratory cells within a unique environment, which effectively enables them to form a 3D structure that replicates the function and form of the respiratory system, serving as a more representative platform for drug research and testing. A prime example of this is MatTek Corporation, a biotechnology company based in the US, which launched an inventive 3D respiratory tissue model, EpiNasal in April 2023. Developed from primary human nasal epithelial cells, EpiNasal imitates the three-dimensional structure and functionality of the nasal epithelium, comprising mucus-producing goblet cells, functional tight junctions, and rhythmically beating cilia. EpiNasal’s launch marked an addition to MatTek’s suite of 3D respiratory tissue models, providing a comprehensive platforms for examining the impact of drugs, chemicals, pathogens, and consumer products on the human respiratory system.

Which Firms Are Making The Biggest Impact In The In-Vitro Lung Model Market?

Major companies operating in the in-vitro lung model market are Thermo Fisher Scientific Inc., Lonza Group AG, PerkinElmer Inc., Charles River Laboratories International Inc., Varian Medical Systems Inc., Epithelix, The Charles Stark Draper Laboratory Inc., STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, AxoSim Technologies LLC, Elveflow, Hesperos Inc., Kugelmeiers Ag, SynVivo Inc., VITROCELL Systems GmbH

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

Which Region Is Forecasted To Lead The In-Vitro Lung Model Market In The Coming Years?

North America was the largest region in the in-vitro lung model market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15837&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model